Ad is loading...
MENU

PMN Stock PMN is expected to report earnings to rise+46% to -7 cents per share on November 13

A.I.dvisor
at Tickeron.com
Loading...
PMN - ProMIS Neurosciences
ProMIS Neurosciences Earnings Graph
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.14
Q3'23
Beat
by $0.14
The last earnings report on June 30 showed earnings per share of -13 cents, beating the estimate of -14 cents. PMN's P/B Ratio (303.030) is very high in comparison to the industry average of (14.171). P/E Ratio (0.000) is within average values for comparable stocks, (100.668). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.979). PMN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (227.804). With 37.11K shares outstanding, the current market capitalization sits at 29.59M.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com